Chinese Drug Regulators Issue New Rules To Increase Safety Standards Of Vaccines
This article was originally published in PharmAsia News
Executive Summary
BEIJING - In the wake of a series of vaccine scandals across China during the past year, triggering sometimes fatal adverse events, China's State FDA is strengthening rules governing the manufacturing, distribution and inspection of vaccines nationwide